Articles from 2019

Guernsey has just approved the use of Cladribine (Mavenclad) for people with highly active MS. Cladribine works by killing certain types of cells made by your immune system.  These cells would normally attack viruses and bacteria that enter the body. However, in MS these cells attack the myelin around the nerves in the brain or spinal cord.  Cladribine therefore has the result of reducing the…

The celebrations for the new website going live are continuing. The MS Society are absolutely delighted with the look of the new website and wish to thank the team at Indulge Media for their generosity. For the full story please follow the link below to the Business Eye CI article: https://www.businesseyeci.com/fresh-new-look-for-ms-society-as-indulge-celebrates-10-years-of-business/